Citius Oncology Inc. (CTOR) Live Share Price, Invest From India

Citius Oncology Inc. Stock Performance

as on June 23, 2026 at 2:46 am IST

Day's Low
$0.68
Day's Price Range
$0.69
$0.69
1.45%
Downside
52 Week's Low
52 Week's High
$0.49
52-Week Price Range
$6.19
$0.69
28.81%
Downside
797.10%
Upside

Citius Oncology Inc. share price movements today

Previous Close: $0.67
Open: $0.69
Volume: 100.8K
Day's Low - High: $0.68 - $0.69
52 Week Low - High: $0.49 - $6.19

Citius Oncology Inc. Historical Returns

1 Month Return: -20.26 %
3 Month Return: + 4.14 %
1 Year Return: -74.54 %
3 Year Return: 0 %
5 Year Return: 0 %

Citius Oncology Inc. Stock Fundamentals & Key Indicators

Check Citius Oncology Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$62.3M

EPS (TTM)

-0.6

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-119.90%

Citius Oncology Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Citius Oncology Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Citius Oncology Inc.	NA	$62.3M	NA	NA	0.00%	NA
United Therapeutics Corporation	BUY	$22.8B	196.69%	19.84	40.62%	NA
Viatris Inc.	HOLD	$17.9B	8.09%	NA	-2.04%	3.05%
Haleon plc (ADR)	BUY	$39.6B	NA	17.92	15.11%	2.15%
ZOETIS INC.	BUY	$33.0B	-57.82%	12.9	28.04%	2.63%

See all

Stock Returns calculator for Citius Oncology Inc. Stock including INR - Dollar returns

The Citius Oncology Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Citius Oncology Inc. investment value today

Current value as on today

₹28,690

Returns

-₹71,310

(-71.31%)

Returns from Citius Oncology Inc. Stock

-₹73,764 (-73.76%)

Dollar Impact

₹2,454 (+2.45%)

Indian Investors' Interest in Citius Oncology Inc. Stock

Search interest for Citius Oncology Inc. Stock has increased by 19% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 23, 2026 to June 22, 2026

Change:19% versus previous 30 day period

Citius Oncology Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	3	1
Gross Profit	-	-	-	-	-	-	-	-	3	1
Operating Income	-4	-4	-4	-6	-6	-7	-4	-4	-5	-28
EBITDA	-4	-4	-4	-6	-6	-7	-4	-4	-4	-26
Interest Expense	-	-	-	-	-	-	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	0	1
Income Before Tax	-4	-4	-4	-6	-6	-7	-5	-4	-5	-26
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-4	-4	-4	-6	-6	-7	-5	-4	-5	-26
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-140.31%	-1595.98%

Citius Oncology Inc. Annual Profit & Loss

All numbers in Millions USD

	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
Operating Income	-9	-12	-20	-23
EBITDA	-4	-12	-20	-23
Interest Expense	-	-	-	0
Depreciation	-	-	-	-
Income Before Tax	-9	-12	-20	-23
Income Tax Expense	1	0	0	1
Net Income	-10	-12	-21	-24
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Citius Oncology Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	0	-22	-6	-7	-5	-4	-5	-26
Operating Cash Flow	0	0	-	-	-	-5	-7	-3
Investing Cash Flow	24	-29	-	-	-	-5	-4	0
Financing Cash Flow	-24	28	-	-	-	15	15	0
Change in Cash	0	0	0	-	-	3	3	-4

Citius Oncology Inc. Annual Cash Flow

All numbers in Millions USD

	Sep 2023	Sep 2024	Sep 2025
Net Income	2	-21	-24
Operating Cash Flow	0	0	-5
Investing Cash Flow	-1	-5	-5
Financing Cash Flow	1	4	15
Change in Cash	0	0	3

Global Institutional Holdings in Citius Oncology Inc.

Funds	Holdings
Advisor Group Holdings, Inc.	0.01%
Omers Administration Corp	0%
Renaissance Technologies Corp	0%
XTX Topco Ltd	0%
Vanguard Group Inc	0.64%

See all

Insights on Citius Oncology Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 91.2% return, outperforming this stock by 165.7%
NEGATIVE IMPACT
Price Dip
In the last 1 month, CTOR stock has moved down by -20.3%

About Citius Oncology Inc.

Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. is a subsidiary of Leonard-Meron Biosciences, Inc.

Organisation	Citius Oncology Inc.
Headquarters	11 Commerce Drive, Cranford, NJ, United States, 07016
Industry	Drug Manufacturers - Specialty & Generic
CEO	Mr. Leonard L. Mazur
E-voting on shares	Click here to vote

Key Management of Citius Oncology Inc.

Name	Title
Mr. Leonard L. Mazur	CEO, President & Executive Chairman
Mr. Myron Z. Holubiak	Secretary & Executive Vice Chairman
Dr. Myron S. Czuczman M.D.	Executive VP & Chief Medical Officer
Mr. Jaime Bartushak	Chief Financial Officer & Treasurer

FAQs

What is Citius Oncology Inc. share price today?

Citius Oncology Inc. share price today is $0.69 as on June 22, 2026 at 9:16 pm IST. Citius Oncology Inc. share today touched a day high of $0.69 and a low of $0.68.

What is the 52 week high and 52 week low for Citius Oncology Inc. share?

Citius Oncology Inc. share touched a 52 week high of $6.19 on June 27, 2025 and a 52 week low of $0.49 on March 30, 2026. Citius Oncology Inc. stock price today i.e. June 22, 2026 at 9:16 pm IST is trending at $0.69,which is 88.85% down from its 52 week high and 40.47% up from its 52 week low.

What is Citius Oncology Inc.'s market capitalisation today?

Citius Oncology Inc. market capitalisation is $0.00T as on June 22, 2026 at 9:16 pm IST.

How to invest in Citius Oncology Inc. Stock (CTOR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Citius Oncology Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Citius Oncology Inc. Shares that will get you 2.1739 shares as per Citius Oncology Inc. share price of $0.69 per share as on June 22, 2026 at 9:16 pm IST.

What is the minimum amount required to buy Citius Oncology Inc. Stock (CTOR) from India?

Indian investors can start investing in Citius Oncology Inc. (CTOR) shares with as little as ₹94.68 or $1 (as of June 22, 2026 at 9:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.80 in Citius Oncology Inc. stock (as per the Rupee-Dollar exchange rate as on June 22, 2026 at 9:37 pm IST). Based on Citius Oncology Inc. share’s latest price of $0.69 as on June 22, 2026 at 9:16 pm IST, you will get 14.4928 shares of Citius Oncology Inc.. Learn more about fractional shares .